» Articles » PMID: 7411314

Aspirin and Dipyridamole Therapy in the Hemolytic-uremic Syndrome

Overview
Journal J Pediatr
Specialty Pediatrics
Date 1980 Sep 1
PMID 7411314
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Guidelines for the management and investigation of hemolytic uremic syndrome.

Igarashi T, Ito S, Sako M, Saitoh A, Hataya H, Mizuguchi M Clin Exp Nephrol. 2014; 18(4):525-57.

PMID: 25099085 DOI: 10.1007/s10157-014-0995-9.


Management of diarrhea-associated hemolytic uremic syndrome in children.

Iijima K, Kamioka I, Nozu K Clin Exp Nephrol. 2008; 12(1):16-9.

PMID: 18175052 DOI: 10.1007/s10157-007-0007-4.


Altered renovascular resistance after spontaneous recovery from hemolytic uremic syndrome.

OBrien J, van Why S, Keller M, Gaudio K, Kennedy T, Siegel N Yale J Biol Med. 1994; 67(1-2):1-14.

PMID: 7645308 PMC: 2590798.


Hemolytic uremic syndrome in a patient on cis-platinum, vinblastine and bleomycin.

van der Meer J, De Vries E, Vriesendorp R, Willemse P, Donker A, Aalders J J Cancer Res Clin Oncol. 1985; 110(2):119-22.

PMID: 2413037 DOI: 10.1007/BF00402723.


Post-transplantation outcome of patients with hemolytic-uremic syndrome: update.

Hebert D, Kim E, Sibley R, Mauer M Pediatr Nephrol. 1991; 5(1):162-7.

PMID: 2025529 DOI: 10.1007/BF00852876.